+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Compound heterozygotes and beta-thalassemia: top-down mass spectrometry for detection of hemoglobinopathies



Compound heterozygotes and beta-thalassemia: top-down mass spectrometry for detection of hemoglobinopathies



Proteomics 14(10): 1232-1238



We have shown previously that liquid extraction surface analysis of dried blood spots coupled to high resolution top-down MS may be applied for the diagnosis of hemoglobin (Hb) variants FS, FAS, FC, FAC, FAD in newborn samples. The objective of the current work was to determine whether the structural variant HbE, compound heterozygote variants FSC and FSD, and β-thalassemia were amenable to diagnosis by this approach. Anonymized residual neonatal dried blood spot samples, taken as part of the routine newborn screening program, were analyzed by liquid extraction surface analysis coupled to high resolution MS/MS. The samples had been previously screened and were known to be FAE, FSC, FSD, or β-thalassemia. Manual analysis of the mass spectra revealed that, in all cases, the variants may be confirmed. Direct surface sampling MS should be considered as an alternative to current screening techniques for the diagnosis of Hb variants.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052269112

Download citation: RISBibTeXText

PMID: 24482221

DOI: 10.1002/pmic.201300316


Related references

Iron metabolism in heterozygotes for hemoglobin E , alpha -thalassemia 1, or beta -thalassemia and in compound heterozygotes for HbE/ beta -thalassemia. American Journal Of Clinical Nutrition: 4, 1026-1031, 2008

Iron metabolism in heterozygotes for hemoglobin E (HbE), alpha-thalassemia 1, or beta-thalassemia and in compound heterozygotes for HbE/beta-thalassemia. American Journal of Clinical Nutrition 88(4): 1026-1031, 2008

Alpha-, beta-, and gamma-mRNA levels in beta-thalassemia; transcriptional and translational differences in heterozygotes, homozygotes, and compound heterozygotes. Hemoglobin 21(1): 27-39, 1997

Diagnosis of three novel hemoglobinopathies beta3 ValfwdarwLeu, beta102 AsnfwdarwIle, alpha87 HisfwdarwGln and a case of Hb Knossos/beta thalassemia by mass spectrometry. Blood 90(10 SUPPL 1 PART 1): 127A, Nov 15, 1997

The prevalence of beta-thalassemia heterozygotes compound alpha-thalassemia in Guangdong district. Zhonghua Xue Ye Xue Za Zhi 22(10): 514-516, 2002

A frequent A gamma-hereditary persistence of fetal hemoglobin in northern Sardinia: its molecular basis and hematologic phenotype in heterozygotes and compound heterozygotes with beta-thalassemia. Human Genetics 79(1): 13-17, 1988

A review of cis-trans interplay between DNA sequences 5' to the (G)gamma- and beta-globin genes among Hb F-Malta-I heterozygotes/homozygotes and beta-thalassemia homozygotes/compound heterozygotes, and the effects of hydroxyurea on the Hb F/F-erythrocyte; the need for large multicenter trials. Hemoglobin 31(2): 279-288, 2007

Molecular characterization and PCR detection of a deletional HPFH: application to rapid prenatal diagnosis for compound heterozygotes of this defect with beta-thalassemia in a Chinese family. American Journal of Hematology 65(3): 183-188, 2000

Globin mRNA in beta-thalassemia heterozygotes with different beta-thalassemia alleles and in heterozygotes for hereditary persistence of fetal hemoglobin. Acta Haematologica 96(3): 162-169, 1996

Molecular detection and haematological analysis of heterozygotes in beta-thalassemia combining deletional alpha-thalassemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi 15(1): 195-197, 2007

Asymptomatic and mild beta-thalassemia in homozygotes and compound heterozygotes for the IVS2+1G>A mutation: Role of the beta-globin gene haplotype. Haematologica 88(10): 1099-1105, 2003

Fetal hemoglobin expression in compound heterozygotes for -117 (G-->A)A gamma HPFH and beta zero 39 nonsense thalassemia. American Journal of Hematology 49(4): 267-270, 1995

A comparative study of Greek nondeletional hereditary persistence of fetal hemoglobin and beta-thalassemia compound heterozygotes. Journal of Molecular Medicine 80(4): 243-247, 2002

Hemoglobin D Ibadan-beta zero thalassemia: detection by neonatal screening and confirmation by electrospray-ionization mass spectrometry. American Journal of Hematology 44(3): 158-161, 1993

Pathophysiology of compound heterozygotes involving hemoglobinopathies and thalassemias. Clinical Laboratory Science 21(4): 240-248, 2009